BlackRock’s Allena Pharmaceuticals, Inc. Common Stock ALNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-228,215
| Closed | -$44K | – | 5888 |
|
|
2022
Q2 | $44K | Sell |
228,215
-30,705
| -12% | -$5.92K | ﹤0.01% | 5346 |
|
|
2022
Q1 | $61K | Sell |
258,920
-5,319
| -2% | -$1.25K | ﹤0.01% | 5299 |
|
|
2021
Q4 | $156K | Buy |
264,239
+8,819
| +3% | +$5.21K | ﹤0.01% | 5084 |
|
|
2021
Q3 | $230K | Buy |
255,420
+5,814
| +2% | +$5.24K | ﹤0.01% | 4884 |
|
|
2021
Q2 | $325K | Buy |
249,606
+59,804
| +32% | +$77.9K | ﹤0.01% | 4718 |
|
|
2021
Q1 | $264K | Buy |
189,802
+25,746
| +16% | +$35.8K | ﹤0.01% | 4629 |
|
|
2020
Q4 | $210K | Buy |
164,056
+28,858
| +21% | +$36.9K | ﹤0.01% | 4398 |
|
|
2020
Q3 | $200K | Buy |
135,198
+1,656
| +1% | +$2.45K | ﹤0.01% | 4310 |
|
|
2020
Q2 | $211K | Buy |
133,542
+12,986
| +11% | +$20.5K | ﹤0.01% | 4279 |
|
|
2020
Q1 | $116K | Sell |
120,556
-7,698
| -6% | -$7.41K | ﹤0.01% | 4254 |
|
|
2019
Q4 | $350K | Sell |
128,254
-25,762
| -17% | -$70.3K | ﹤0.01% | 4165 |
|
|
2019
Q3 | $606K | Buy |
154,016
+38,360
| +33% | +$151K | ﹤0.01% | 4068 |
|
|
2019
Q2 | $471K | Sell |
115,656
-492,237
| -81% | -$2M | ﹤0.01% | 4148 |
|
|
2019
Q1 | $4.27M | Buy |
607,893
+25,922
| +4% | +$182K | ﹤0.01% | 3429 |
|
|
2018
Q4 | $3.17M | Buy |
581,971
+4,528
| +0.8% | +$24.7K | ﹤0.01% | 3503 |
|
|
2018
Q3 | $6.2M | Buy |
577,443
+9,736
| +2% | +$105K | ﹤0.01% | 3395 |
|
|
2018
Q2 | $7.4M | Buy |
567,707
+336,053
| +145% | +$4.38M | ﹤0.01% | 3341 |
|
|
2018
Q1 | $2.55M | Buy |
231,654
+4,879
| +2% | +$53.8K | ﹤0.01% | 3575 |
|
|
2017
Q4 | $2.28M | Buy |
+226,775
| New | +$2.28M | ﹤0.01% | 3610 |
|